PHARMACEUTICALLY ACTIVE DISUBSTITUTED PYRIDINE DERIVATIVES
The present invention relates to disubstituted pyridine derivatives of formula (l) and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic disease...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
17.09.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to disubstituted pyridine derivatives of formula (l) and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of infectious diseases, including opportunistic diseases, immunological diseases, autoimmune diseases, cardiovascular diseases, cell proliferative diseases, inflammation, erectile dysfunction and stroke, and pharmaceutical compositions containing at least one of said disubstituted pyridine derivatives and/or pharmaceutically acceptable salts thereof. Furthermore, the present invention relates to the use of said disubstituted pyridine derivatives as inhibitors for a protein kinase. (see formula I)
La présente invention porte sur des dérivés de pyridine disubstitués et/ou des sels pharmaceutiquement acceptables de ceux-ci, sur l'utilisation de ces dérivés comme agents pharmaceutiquement actifs, en particulier pour la prophylaxie et/ou le traitement de maladies infectieuses, dont les maladies opportunistes, les maladies immunologiques, les maladies auto-immunes, les maladies cardiovasculaires, les maladies prolifératives des cellules, une inflammation, un dysfonctionnement érectile et l'accident vasculaire cérébral, et sur des compositions pharmaceutiques contenant au moins l'un desdits dérivés de pyridine disubstitués et/ou sels pharmaceutiquement acceptables de ceux-ci. En outre, la présente invention porte sur l'utilisation desdits dérivés de pyridine disubstitués comme inhibiteurs pour une protéine kinase. |
---|---|
Bibliography: | Application Number: CA20122826459 |